- The overview presentation will review some of the Company's recent achievements, including highly promising interim results from the Company's pancreatic cancer safety and feasibility trial as well as robust long-term data analyzed across four clinical trials -
- The Company will also be featured at the Biotech Showcase™ occurring in parallel, and will host institutional investor meetings at both conferences -
JERUSALEM, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that Chairman and CEO Uzi Sofer and CFO Raphi Levy will present a corporate overview and update at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 10:30 am PT / 1:30 pm ET, in San Francisco, CA, and will ...